Fuxin Zhao

1.9k citations
52 papers · 1.2k indexed · h-index 22
Topics
Mitochondrial Function and Pathology (31 papers)ATP Synthase and ATPases Research (23 papers)Metabolism and Genetic Disorders (22 papers)

In The Last Decade

Fuxin Zhao

51 papers receiving 1.2k citations

Peers

Fuxin Zhao
Comparison fields: 5 of 80
  • Molecular Biology 889
  • Clinical Biochemistry 362
  • Ophthalmology 262
  • Radiology, Nuclear Medicine and Imaging 175
  • Epidemiology 151
Replace D.J. Sidjanin with:
D.J. Sidjanin United States
Yasushi Isashiki Japan
Nallathambi Jeyabalan India
Eisuke Shimizu Japan
Yanhua Qi China
James R. Lupski United States
N. M. McKechnie United Kingdom
R. W. Beuerman United States
Alexander Ionides United Kingdom
Arpita Bharadwaj United States
Fuxin Zhao relative to D.J. Sidjanin United States D.J. Sidjanin's profile →
Citations per field
00.5×6.2×
D.J. Sidjanin · 1×
Citations per year

Countries citing papers authored by Fuxin Zhao

Since Specialization
Citations

This map shows the geographic impact of Fuxin Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fuxin Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fuxin Zhao more than expected).

Fields of papers citing papers by Fuxin Zhao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fuxin Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fuxin Zhao. The network helps show where Fuxin Zhao may publish in the future.

Co-authorship network of co-authors of Fuxin Zhao

This figure shows the co-authorship network connecting the top 25 collaborators of Fuxin Zhao. A scholar is included among the top collaborators of Fuxin Zhao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fuxin Zhao. Fuxin Zhao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 8
3 13
4 19
5 17
6 15
7 1
8 17
9 46
10 21
11 2
12 2
13 1
14 29
15 15
16 91
17 12
18 60
19 28
20 47

About Fuxin Zhao

Fuxin Zhao is a scholar working on Clinical Biochemistry, Ophthalmology and Molecular Biology, having authored 52 papers that have together received 1.2k indexed citations. Recurring topics across this work include Mitochondrial Function and Pathology (31 papers), ATP Synthase and ATPases Research (23 papers) and Metabolism and Genetic Disorders (22 papers). The work is most often cited by research in Clinical Biochemistry (362 citations), Ophthalmology (262 citations) and Molecular Biology (889 citations). Fuxin Zhao has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Xiangtian Zhou, Min‐Xin Guan, Jia Qu, Yi Tong, Juanjuan Zhang, Li Yang, Yanhong Sun, Yanchun Ji, Min Liang and Qi-Ping Wei. Their work appears in journals such as Journal of Clinical Investigation, PLoS ONE and Biochemical and Biophysical Research Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026